Adaphostin promotes caffeine-evoked autocrine Fas-mediated death pathway activation in Bcr/Abl-positive leukaemia cells

Biochemical Journal

Volumn 439, Issue 3, 2011, Pages 453-467

  Liu, Wen Hsin ^a   Chang, Long Sen ^b  

^a NATIONAL SUN YAT SEN UNIVERSITY   (Taiwan)

^b KAOHSIUNG MEDICAL UNIVERSITY   (Taiwan)

Author keywords

Activating transcription factor 2 (ATF 2); Adaphostin; c Jun; c Jun N terminal kinase 1 (JNK1); Caffeine; Fas FasL; p38 mitogen activated protein kinase (p38 MAPK)

Indexed keywords

ACTIVATING TRANSCRIPTION FACTOR 2; ADAPHOSTIN; APOPTOSIS SIGNAL REGULATING KINASE 1; BCR ABL PROTEIN; CAFFEINE; CALCIUM ION; FAS ASSOCIATED DEATH DOMAIN PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE P38; PROTEIN KINASE B; REACTIVE OXYGEN METABOLITE; SMALL INTERFERING RNA; STRESS ACTIVATED PROTEIN KINASE;

ARTICLE; AUTOCRINE EFFECT; CANCER THERAPY; CELL STRAIN K 562; CONTROLLED STUDY; DOWN REGULATION; ENZYME INDUCTION; ENZYME REPRESSION; HUMAN; HUMAN CELL; LEUKEMIA CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; UPREGULATION;

ADAMANTANE; AUTOCRINE COMMUNICATION; CAFFEINE; FAS LIGAND PROTEIN; FUSION PROTEINS, BCR-ABL; HUMANS; HYDROQUINONES; K562 CELLS; MAP KINASE SIGNALING SYSTEM; U937 CELLS;

EID: 80054022806     PISSN: 02646021     EISSN: 14708728     Source Type: Journal    
DOI: 10.1042/BJ20110725     Document Type: Article

References (61)

1. Gururajanna, B., Al-Katib, A. A., Li, Y. W., Aranha, O., Vaitkevicius, V. K. and Sarkar, F. H. (1999) Molecular effects of taxol and caffeine on pancreatic cancer cells. Int. J. Mol. Med. 4, 501-507
2. Jang, M. H., Shin, M. C., Kang, I. S., Baik, H. H., Cho, Y. H., Chu, J. P., Kim, E. H. and Kim, C. J. (2002) Caffeine induces apoptosis in human neuroblastoma cell line SK-N-MC. J. Korean Med. Sci. 17, 674-678
3. Okano, J. I., Nagahara, T., Matsumoto, K. and Murawaki, Y. (2008) Caffeine inhibits the proliferation of liver cancer cells and activates the MEK/ERK/EGFR signaling pathway. Basic Clin. Pharmacol. Toxicol. 102, 543-551 (Pubitemid 351691962)
4. Gude, R. P., Menon, L. G. and Rao, S. G. (2001) Effect of caffeine, a xanthine derivative, in the inhibition of experimental lung metastasis induced by B16F10 melanoma cells. J. Exp. Clin. Cancer Res. 20, 287-292 (Pubitemid 32641075)
5. Yang, H., Rouse, J., Lukes, L., Lancaster, M., Veenstra, T., Zhou, M., Shi, Y., Park, Y. G. and Hunter, K. (2004) Caffeine suppresses metastasis in a transgenic mouse model: a prototype molecule for prophylaxis of metastasis. Clin. Exp. Metastasis 21, 719-735 (Pubitemid 40755012)
6. 2+/ROS-mediated suppression of ERK/c-Fos pathway and activation of p38 MAPK/c-Jun pathway. J. Cell. Physiol. 224, 775-785
7. 2/M DNA damage checkpoint by inhibiting ataxia-telangiectasia-mutated kinase activity. J. Biol. Chem. 275, 10342-10348
8. Foukas, L. C., Daniele, N., Ktori, C., Anderson, K. E., Jensen, J. and Shepherd, P. R. (2002) Direct effects of caffeine and theophylline on p110 δ and other phosphoinositide 3-kinases. Differential effects on lipid kinase and protein kinase activities. J. Biol. Chem. 277, 37124-37130
9. 2/M arrest and apoptosis via a novel p53-dependent pathway in NB4 promyelocytic leukemia cells. J. Cell. Physiol. 196, 276-283
10. Lu, P. Z., Lai, C. Y. and Chan, W. H. (2008) Caffeine induces cell death via activation of apoptotic signal and inactivation of survival signal in human osteoblasts. Int. J. Mol. Sci. 9, 698-718
11. Nakaso, K., Ito, S. and Nakashima, K. (2008) Caffeine activates the PI3K/Akt pathway and prevents apoptotic cell death in a Parkinson's disease model of SH-SY5Y cells. Neurosci. Lett. 432, 146-150
12. van den Berg, H. W. and Roberts, J. J. (1975) Post-replication repair of DNA in Chinese hamster cells treated with cis platinum (II) diamine dichloride. Enhancement of toxicity and chromosome damage by caffeine. Mutat. Res. 33, 279-284
13. Takahashi, M., Yanoma, S., Yamamoto, Y., Rino, Y., Amano, T. and Imada, T. (1998) Combined effect of CDDP and caffeine against human gastric cell line in vivo. Anticancer Res. 18, 4399-4401 (Pubitemid 29043666)
14. Fingert, H. J., Pu, A. T., Chen, Z. Y., Googe, P. B., Alley, M. C. and Pardee, A. B. (1998) In vivo and in vitro enhanced antitumor effects by pentoxifylline in human cancer cells treated with thiotepa. Cancer Res. 48, 4375-4381
15. Tomita, K. and Tsuchiya, H. (1989) Caffeine enhancement of the effect of anticancer agents on human sarcoma cells. Jpn. J. Cancer Res. 80, 83-88 (Pubitemid 20027203)
16. Petru, E., Boike, G. and Sevin, B. U. (1990) Potentiation of cisplatin cytotoxicity by methylxanthines in vitro. J. Cancer Res. Clin. Oncol. 116, 431-433 (Pubitemid 20359899)
17. Sadzuka, Y., Mochizuki, E. and Takino, T. (1995) Mechanism of caffeine modulation of the antitumor activity of adriamycin. Toxicol. Lett. 75, 39-49
18. Kawahara, M., Takahashi, Y., Takazawa, K., Tsuchiya, H., Tomita, K., Yokogawa, K. and Miyamoto, K. I. (2008) Caffeine dose-dependently potentiates the antitumor effect of cisplatin on osteosarcomas. Anticancer Res. 28, 1681-1686
19. Hayashi, K., Tsuchiya, H., Yamamoto, N., Shirai, T., Yamauchi, K., Takeuchi, A., Kawahara, M., Miyamoto, K. I. and Tomita, K. (2009) Impact of serum caffeine monitoring on adverse effects and chemotherapeutic responses to caffeine-potentiated chemotherapy for osteosarcoma. J. Orthop. Sci. 14, 253-258
20. Faderl, S., Talpaz, M., Estrov, Z., O'Brien, S., Kurzrock, R. and Kantarjian, H. M. (1999) The biology of chronic myeloid leukemia. N. Eng. J. Med. 341, 167-172
21. Hochhaus, A., Kreil, S., Corbin, A. S., La Rosee, P., Muller, M. C., Lahaye, T., Hanfstein, B., Schoch, C., Cross, N. C., Berger, U. et al. (2002) Molecular and chromosomal mechanisms of resistance to imatinib (STI571) therapy. Leukemia 16, 2190-2196 (Pubitemid 35331833)
22. Donata, N. J., Wu, J. Y., Stapley, J., Lin, H., Arlinghaus, R., Aggarwal, B. B., Shishodia, S., Albitar, M., Hayes, K., Kantarjian, H. and Talpaz, M. (2004) Imatinib mesylate resistance through BCR-ABL independence in chronic myelogenous leukemia. Cancer Res. 64, 672-677 (Pubitemid 38120909)
23. Chandra, J., Hackbarth, J., Loegering, S. L. D., Bone, N., Bruzek, L. M., Narayanan, V. L., Adjei, A. X., Kay, N. E., Tefferi, A., Karp, J. E. et al. (2003) Involvement of reactive oxygen species in adaphostin-induced cytotoxicity in human leukemia cells. Blood 102, 4512-4519 (Pubitemid 37494118)
24. Kantarjian, H. M., Giles, F., Quintas-Cardama, A. and Cortes, J. (2007) Important therapeutic targets in chronic myelogenous leukemia. Clin. Cancer Res. 13, 1089-1097 (Pubitemid 46424047)
25. Gamas, P., Marchetti, S., Puissant, A., Grosso, S., Jacquel, A., Colosetti, P., Pasquet, J. M., Mahon, F. X., Cassuto, J. P. and Auberger, P. (2009) Inhibition of imatinib-mediated apoptosis by the caspase-cleaved form of the tyrosine kinase Lyn in chronic myelogenous leukemia cells. Leukemia 23, 1500-1506
26. Wei, G., Rafiyath, S. and Liu, D. (2010) First-line treatment for chronic myeloid leukemia: dasatinib, nilotinib, or imatinib. J. Hematol. Oncol. 3, 47
27. Chandra, J., Tracy, J., Loegering, D., Flatten, K., Verstovsek, S., Beran, M., Gorre, M., Estrov, Z., Donato, N., Talpaz, M. et al. (2006) Adaphostin-induced oxidative stress overcomes BCR/ABL mutation-dependent and -independent imatinib resistance. Blood 107, 2501-2506 (Pubitemid 43345574)
28. Kuriakose, P. (2005) Targeted therapy for hematologic malignancies. Cancer Control 12, 82-90
29. De Poeta, G., Bruno, A., Del Principe, M. I., Venditti, A., Maurillo, L., Buccisano, F., Stasi, R., Neri, B., Luciano, F., Siniscalchi, A. et al. (2008) Deregulation of the mitochondrial apoptotic machinery and development of molecular targeted drugs in acute myeloid leukemia. Curr. Cancer Drug Targets 8, 207-222 (Pubitemid 351666857)
30. Orrenius, S., Zhivotovsky, B. and Nicotera, P. (2003) Regulation of cell death: the calcium-apoptosis link. Nat. Rev. Mol. Cell Biol. 4, 552-565 (Pubitemid 36773407)
31. Avery, S. V. (2011) Molecular targets of oxidative stress. Biochem. J. 434, 201-210
32. Daly, J. W. (2007) Caffeine analogs: biomedical impact. Cell. Mol. Life Sci. 64, 2153-2169
33. Hengartner, M. O. (2000) The biochemistry of apoptosis. Nature 407, 700-706
34. Thorburn, A (2004) Death receptor-induced cell killing. Cell. Signalling 16, 139-144
35. Kasibhatla, S., Brunner, T., Genestier, L., Echeverri, F., Mahboubi, A. and Green, D. R. (1998) DNA damaging agents induce expression of Fas ligand and subsequent apoptosis in T lymphocytes via the activation of NF-κB and AP-1. Mol. Cell 1, 543-551 (Pubitemid 128374690)
36. Faris, M., Latinis, K. M., Kempiak, S. J., Koretzky, G. A. and Nel, A. (1998) Stress-induced Fas ligand expression in T cells is mediated through a MEK kinase 1-regulated response element in the Fas ligand promoter. Mol. Cell. Biol. 18, 5414-5424 (Pubitemid 28388124)
37. Kuo, W. H., Chen, J. H., Lin, H. H., Chen, B. C., Hsu, J. D. and Wang, C. J. (2005) Induction of apoptosis in the lung tissue from rats exposed to cigarette smoke involves p38/JNK MAPK pathway. Chemico-Biol. Inter. 155, 31-42
38. Lo, C. W., Huang, H. P., Lin, H. M., Chien, C. T. and Wang, C. J. (2007) Effect of Hibiscus anthocyanins-rich extract induces apoptosis of proliferating smooth muscle cell via activation of p38 MAPK and p53 pathway. Mol. Nutr. Food Res. 51, 1452-1460
39. Fujii, K., Goldman, E. H., Park, H. R., Zhang, L., Chen, J. and Fu, H. (2004) Negative control of apoptosis signal-regulating kinase-1 through phosphorylation of Ser-1034. Oncogene 23, 5099-5104 (Pubitemid 38938745)
40. Sanchez-Perez, I., Martínez-Gomariz, M., Williams, D., Keyse, S. M. and Perona, R. (2000) CL100/MKP-1 modulates JNK activation and apoptosis in response to cisplatin. Oncogene 19, 5142-5152
41. Venugopal, S. K., Chen, J., Zhang, Y., Clemens, D., Follenzi, A. and Zern, M. A. (2007) Role of MAPK phosphatase-1 in sustained activation of JNK during ethanol-induced apoptosis in hepatocyte-like VL-17A cells. J. Biol. Chem. 282, 31900-31908 (Pubitemid 350106461)
42. 2-terminal kinase-mediated apoptosis via NF-κB regulation. J. Biol. Chem. 283, 21011-21023
43. von Gise, A., Lorenz, P., Wellbrock, C., Hemmings, B., Berberich-Siebelt, F., Rapp, U. R. and Troppmair, J. (2001) Apoptosis suppression by Raf-1 and MEK1 requires MEK- and phosphatidylinositol 3-kinase-dependent signals. Mol. Cell. Biol. 21, 2324-2336
44. Sato, S., Fujita, N. and Tsuruo, T. (2004) Involvement of 3-phosphoinositide-dependent protein kinase-1 in the MEK/MAPK signal transduction pathway. J. Biol. Chem. 279, 33759-33767 (Pubitemid 39063025)
45. Chen, K. C., Chiou, Y. L. and Chang, L. S. (2009) JNK1/c-Jun and p38α MAPK/ATF-2 pathways are responsible for upregulation of Fas/FasL in human chronic myeloid leukemia K562 cells upon exposure to Taiwan cobra phospholipase A2. J. Cell. Biochem. 108, 612-620
46. Lasham, A., Lindridge, E., Rudert, F., Onrust, R. and Watson, J. (2000) Regulation of the human fas promoter by YB-1, Purα and AP-1 transcription factors. Gene 252, 1-13 (Pubitemid 30618808)
47. Crist, S. A., Griffith, T. S. and Ratliff, F. L. (2003) Structure/function analysis of the murine CD95L promoter reveals the identification of a novel transcriptional repressor and functional CD28 response element. J. Biol. Chem. 278, 35950-35958 (Pubitemid 37139913)
48. Christmann, M., Tomicicm, M. T., Aasland, D. and Kaina, B. (2007) A role for UV-light-induced c-Fos: stimulation of nucleotide excision repair and protection against sustained JNK activation and apoptosis. Carcinogenesis 28, 183-190 (Pubitemid 44942642)
49. McPherson, P. S., Kim, Y. K., Valdivia, H., Knudson, C. M., Takekura, H., Franzini-Armstrong, C., Coronado, R. and Campbell, K. P. (1991) The brain ryanodine receptor: a caffeine-sensitive calcium release channel. Neuron 7, 17-25
50. Kang, S. S., Han, K. S., Ku, B. M., Lee, Y. K., Hong, J., Shin, Y. H., Almonte, A. G., Woo, D. H., Brat, D. J., Hwang, E. M. et al. (2010) Caffeine-mediated inhibition of calcium release channel inositol 1,4,5-trisphosphate receptor subtype 3 blocks glioblastoma invasion and extends survival. Cancer Res. 70, 1173-1183
51. 2+-activated NADPH oxidase in testis, spleen, and lymph nodes. J. Biol. Chem. 276, 37594-37601
52. Chakraborty, S. and Massey, V. (2002) Reaction of reduced flavins and flavoproteins with diphenyliodonium chloride. J. Biol. Chem. 277, 41507-41516 (Pubitemid 35257453)
53. Ribeiro, J. A. and Sebastiao, A. M. (2010) Caffeine and adenosine. J. Alzheimer's Dis. 20, S3-S15
54. Mlejnek, P. and Dolezel, P. (2010) Induction of apoptosis by A3 adenosine receptor agonist N-(3-iodobenzyl)-adenosine-5′-N-methylcarboxamide in human leukaemia cells: a possible involvement of intracellular mechanism. Acta Physiol. 199, 171-179
55. Merighi, S., Benini, A., Mirandola, P., Gessi, S., Varani, K., Simioni, C., Leung, E., Maclennan, S., Baraldi, P. G. and Borea, P. A. (2007) Caffeine inhibits adenosine-induced accumulation of hypoxia-inducible factor-1α, vascular endothelial growth factor, and interleukin-8 expression in hypoxic human colon cancer cells. Mol. Pharmacol. 72, 395-406 (Pubitemid 47124120)
56. Carlo-Stella, C., Regazzi, E., Sammarelli, G., Colla, S., Garau, D., Gazit, A., Savoldo, B., Cilloni, D., Tabilio, A., Levitzki, A. and Rizzoli, V. (1999) Effects of the tyrosine kinase inhibitor AG957 and an Anti-Fas receptor antibody on CD34(+) chronic myelogenous leukemia progenitor cells. Blood 93, 3973-3982 (Pubitemid 29249847)
57. Mow, B. M., Chandra, J., Svingen, P. A., Hallgren, C. G., Weisberg, E., Kottke, T. J., Narayanan, V. L., Litzow, M. R., Griffin, J. D., Sausville, E. A. et al. (2002) Effects of the Bcr/abl kinase inhibitors STI571 and adaphostin (NSC 680410) on chronic myelogenous leukemia cells in vitro. Blood 99, 664-671 (Pubitemid 34533106)
58. Zhang, M., Hu, H., Zhang, X., Lu, W., Lim, J., Eysteinsson, T., Jacobson, K. A., Laties, A. M. and Mitchell, C. H. (2010) The A3 adenosine receptor attenuates the calcium rise triggered by NMDA receptors in retinal ganglion cells. Neurochem. Int. 56, 35-41
59. Ledo, A., Miners, J. O., Robson, R. and Birkett, D. J. (1986) Assessment of caffeine exposure: caffeine content of beverages, caffeine intake, and plasma concentrations of methylxanthines. Clin. Pharmacol. Ther. 39, 54-59 (Pubitemid 16166966)
60. Fredholm, B. B. (1980) Are methylxanthine effects due to antagonism of endogenous adenosine? Trends Pharmacol. Sci. 1, 129-132
61. Testa, U. and Riccioni, R. (2007) Deregulation of apoptosis in acute myeloid leukemia. Haematologica 92, 81-94 (Pubitemid 46237556)